Michael Nohaile

Michael Nohaile appears in our data through filings on Fulgent Genetics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 1 August 2022 to 15 May 2025, the count stands at 4 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The latest filing, published on 19 May 2025, reports a share grant in Fulgent Genetics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.